Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044

LIFEMD, INC.

(LFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LIFEMD, INC. : Change in Directors or Principal Officers (form 8-K)

07/22/2021 | 05:20pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Chief Acquisition Officer Compensation

Effective July 19, 2021, LifeMD, Inc. (the "Company") and Nicholas Alvarez, its Chief Acquisition Officer, entered into the First Amendment (the "Amendment") to the Amended and Restated Employment Agreement dated December 8, 2020 (the "Agreement") between the Company and Mr. Alvarez to (i) increase Mr. Alvarez's base salary from $172,400 to $300,000 per year, (ii) specify that the discretionary Performance Bonus (as defined in the Amendment) may be up to $125,000 and (iii) change the governing law of the Agreement to New York.

Item 5.02 of this Current Report on Form 8-K contains only a brief description of the material terms of the Amendment and does not purport to be a complete description of the rights and obligations of the parties to the Amendment, and such description is qualified in its entirety by reference to the full text of the Amendment, which is attached as Exhibit 10.1 to this current report on Form 8-K and is incorporated herein by reference.




Item 9.01 Exhibits



(d)



Exhibit No.   Exhibit
10.1            First Amendment to the Amended and Restated Employment Agreement
              between Nicholas Alvarez and LifeMD, Inc., dated July 19, 2021

© Edgar Online, source Glimpses

All news about LIFEMD, INC.
08:01aLIFEMD : to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
AQ
09/15INSIDER BUY : LifeMD
MT
09/13LIFEMD : Industry veteran brings deep financial and management expertise to LifeMD as comp..
PU
09/13LIFEMD, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
09/13LIFEMD : Appoints Seasoned Investor Naveen Bhatia to Board of Directors
AQ
09/13LifeMD, Inc. Appoints Naveen Bhatia to its Board of Directors
CI
09/08LIFEMD : to Present at the H.C. Wainwright Annual Global Investment Conference
AQ
08/30LIFEMD : to Adopt Prescryptive Health Digital Pharmacy, Prescriptions Platform for Telehea..
MT
08/30LIFEMD : Partners With Prescryptive Health, Expanding Convenience and Affordability for Pa..
AQ
08/30LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for P..
CI
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 97,8 M - -
Net income 2021 -57,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,37x
Yield 2021 -
Capitalization 192 M 192 M -
Capi. / Sales 2021 1,96x
Capi. / Sales 2022 1,32x
Nbr of Employees 56
Free-Float 67,2%
Chart LIFEMD, INC.
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 7,22 $
Average target price 30,00 $
Spread / Average Target 316%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Independent Director & Chief Medical Officer-US
Stefan Galluppi Director & Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.10.57%181
AMAZON.COM, INC.6.31%1 699 478
JD.COM, INC.-15.64%115 092
WAYFAIR INC.24.27%29 155
ETSY, INC.22.34%27 551
ALLEGRO.EU SA-26.30%16 294